AstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Wave

May 27, 2026 11:33 AM EDT News Briefing As­traZeneca's breast can­cer PDU­FA de­layed; Ar­row­head aims at same obe­si­ty tar­get as Wave ENDPOINTS Plus news about Kail­era, Al­fasig­ma, Jun­shi and Ku­ra. ⏰ FDA de­lays As­traZeneca’s camizes­trant PDU­FA date: The FDA has ex­tend­ed its PDU­FA … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER